Logo image
Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma
Journal article   Peer reviewed

Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma

J. Lu, D. Wood, E. Ingley, S. Kõks and D. Wong
Molecular Biology Reports
2021
url
Link to Published Version *Subscription may be requiredView

Abstract

Well-differentiated liposarcoma (WDLPS) is the most frequent subtype of liposarcoma and may transform into dedifferentiated liposarcoma (DDLPS) which is a more aggressive subtype. Retroperitoneal lesions of WDLPS/DDLPS tend to recur repeatedly due to incomplete resections, and adjuvant chemotherapy and radiotherapy have little effect on patient survival. Consequently, identifying therapeutic targets and developing targeted drugs is critical for improving the outcome of WDLPS/DDLPS patients. In this review, we summarised the mutational landscape of WDLPS/DDLPS from recent studies focusing on potential oncogenic drivers and the development of molecular targeted drugs for DDLPS. Due to the limited number of studies on the molecular networks driving WDLPS to DDLPS development, we looked at other dedifferentiation-related tumours to identify potential parallel mechanisms that could be involved in the dedifferentiation process generating DDLPS.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.118 Soft Tissue, Bone & Nerve Cancers
1.118.300 Sarcoma Research
Web Of Science research areas
Biochemistry & Molecular Biology
ESI research areas
Molecular Biology & Genetics
Logo image